Who
Mark DiPaolo
Director
Company insider
Files Form 4 as: Director, Innoviva; Director, Amarin Corporation; Director, Novelion Therapeutics.
In numbers
- Trades disclosed
- 28
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 1 Aug 2017
- Last trade
- 4 May 2026
- Last filed
- 6 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 May 2026filed 6 May 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —9,786 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —9,786 at $0.00 | filing |
| 19 May 2025filed 21 May 2025 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 19 May 2025filed 21 May 2025 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —12,077 at $0.00 | filing |
| 18 Apr 2025filed 22 Apr 2025 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code M | —838 at $0.00 | filing |
| 18 Apr 2025filed 22 Apr 2025 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code M | —838 | filing |
| 18 Apr 2025filed 22 Apr 2025 | AMRN Amarin CorporationBiotechnology | SEC FORM 4 Code F | $3,981437 at $9.11 | filing |
| 17 Jun 2024filed 20 Jun 2024 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 17 Jun 2024filed 20 Jun 2024 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —13,923 at $0.00 | filing |
| 18 Apr 2024filed 19 Apr 2024 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —179,795 at $0.00 | filing |
| 18 Apr 2024filed 19 Apr 2024 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,287 at $0.00 | filing |
| 21 Jul 2023filed 21 Jul 2023 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —284,598 at $0.00 | filing |
| 21 Jul 2023filed 21 Jul 2023 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —167,411 at $0.00 | filing |
| 21 Jul 2023filed 21 Jul 2023 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —94,866 at $0.00 | filing |
| 21 Jul 2023filed 21 Jul 2023 | AMRN Amarin Corporationoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,804 at $0.00 | filing |
| 22 May 2023filed 24 May 2023 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 22 May 2023filed 24 May 2023 | INVA InnovivaPharmaceuticals | SEC FORM 4 Code A | —16,495 at $0.00 | filing |
| 25 Apr 2022filed 27 Apr 2022 | INVA Innovivaoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.